Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women

AIDS Research and Human Retroviruses

Volumn 25, Issue 10, 2009, Pages 997-1004

  Mansoor, Ather ^a   Althoff, Keri ^b   Gange, Stephen ^b   Anastos, Kathryn ^c   Dehovitz, Jack ^a   Minkoff, Howard ^d   Kaplan, Robert ^c   Holman, Susan ^a   Lazar, Jason M ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TRIACYLGLYCEROL; VIRUS ANTIBODY;

ADULT; ANEMIA; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; KIDNEY DISEASE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNIVARIATE ANALYSIS;

ADULT; ANEMIA; COMORBIDITY; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; MIDDLE AGED; NATRIURETIC PEPTIDES;

EID: 70449476946     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0038     Document Type: Article

References (44)

1. Barbaro G, Di Lorenzo G, Grisorio B, and Barbarini G: Cardiac involvement in the acquired immunodeficiency syndrome: A multicenter clinical-pathological study. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS Investigators. AIDS Res Hum Retroviruses 1998;14: 1071-1077.
2. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, et al.: B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: Comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006;47:742-748.
3. Bettencourt P, Ferreira A, Dias P, Castro A, Martins L, and Cerqueira-Gomes M: Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology 2000;93:19-25.
4. Martinez-Rumayor A, Richards AM, Burnett JC, and Januzzi JL Jr: Biology of natriuretic peptides. Am J Cardiol 2008;101:3-8.
5. Silver MA, Maisel A, Yancy CW, et al.: BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail 2004;10:1-30.
6. Fijalkowska A, Kurzyna M, Torbicki A, Szewczyk G, Florczyk M, PruZsczyk M, et al.: Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006;129:1313-1321.
7. Ashley KE, Galla JM, and Nicholls SJ: Brain natriuretic peptides as biomarkers for atherosclerosis. Prev Cardiol 2008;11:172-176.
8. Levy WS, Simon GL, Rios JC, and Ross AM: Prevalence of cardiac abnormalities in human immunodeficiency virus infection. Am J Cardiol 1989;63:86-89.
9. Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, D'Arminio Monforte A, et al.: Cardiovascular risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD Study. AIDS 2003;17:1179-1193.
10. Uusimaa P, Tokola H, Ylitalo A, Vuolteenaho O, Ruskoaho H, Risteli J, et al.: Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension. Int J Cardiol 2004;97:251-256.
11. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al.: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350: 655-663.
12. Carrillo-Jimenez R, Treadwell TL, Goldfine H, Buenano A, Lamas GA, and Hennekens CH: Brain natriuretic peptide and HIV-related cardiomyopathy. AIDS Reader 2002;12: 501-503, 508.
13. Lebech AM, Gerstoft J, Hesse B, Petersen CL, and Kjaer A: Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography. Am Heart J 2004;147:482-488.
14. Breuckmann F, Nassenstein K, Kondratieva J, Esser S, Erbel R, Potthoff A, et al.: German Heart Failure Network; Competence Network HIV/AIDS: MR characterization of cardiac abnormalities in HIV+ individuals with increased BNP levels. Eur J Med Res 2007;29:185-190.
15. Kristoffersen US, Lebech AM, Gerstoft J, Hesse B, Petersen CL, Gutte H, et al.: Right and left cardiac function in HIVinfected patients investigated using radionuclide ventriculography and brain natriuretic peptide: A 5-year follow-up study. HIV Med 2008;9:180-186.
16. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, et al.: The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998;9: 117-125.
17. Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, et al.: The Women's Interagency HIV Study: An observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol 2005;12:1013-1019.
18. De Lemos JA and Hildebrandt P: Amino-terminal pro-B-type natriuretic peptides: Testing in general populations. Am J Cardiol 2008;101:16-20.
19. Hessol NA, Anastos K, Levine AM, Ameli N, Cohen M, Young M, et al.: Factors associated with incident selfreported AIDS among women enrolled in the women's interagency HIV study (WIHS). WIHS Collaboratorive Study Group. AIDS Res Hum Retroviruses 2000;16:1105-1111.
20. Panel on Clinical Practices for Treatment of HIV Infection: Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents. Department of Health and Human Services (DHHS), Washington, DC, October 10, 2006.
21. National Center for Health Statistics: The Third National Health and Examination Survey Reference Manuals and Reports. CD-ROM, 2002. National Center for Health Statistics, Hyattsville, MD, 1996.
22. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183.
23. Friedewald WT, Levy RI, and Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
24. Petersdorf RG, Adams RD, Braunwald E, et al., eds.: Harrison's laboratory values of clinical importance. In: Principles of Internal Medicine. McGraw-Hill, New York, 1983.
25. Levey AS, Greene T, Kusek JW, and Beck GL: A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 2000;11:155A.
26. Jacob AJ, Sutherland GR, Bird AG, Brettle RP, Ludlam CA, McMillan A, et al.: Myocardial dysfunction in patients infected with HIV: Prevalence and risk factors. Br Heart J 1992;68:549-553.
27. Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, Jacobsen SJ, Heublein DM, and Burnett JC Jr: Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: Determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 2006;47:345-353.
28. Bibbins-Domingo K, Gupta R, Na B, Wu AH, Schiller NB, and Whooley MA: N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 2007;297:169-176.
29. Struthers A and Lang C: The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent 'pancardiac' target organ damage: BNP/ N-BNP could become for the heart what microalbuminuria is for the kidney. Eur Heart J 2007;28:1678-1682.
30. Ogawa K, Oida A, Sugimura H, et al.: Clinical significance of blood brain natriuretic peptide level measurement in the detection of heart disease in untreated outpatients: Comparison of electrocardiography, chest radiography and echocardiography. Circ J 2002;66:122-126.
31. März W, Tiran B, Seelhorst U, Wellnitz B, Bauersachs J, Winkelmann BR, et al.: LURIC Study Team: N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: The Ludwigshafen Risk and Cardiovascular Health Study. Clin Chem 2007;53:1075-1083. (Pubitemid 46867524)
32. Matsumori A, Shimada T, Chapman NM, Tracy SM, and Mason JW: Myocarditis and heart failure associated with hepatitis C infection. J Card Fail 2006;12:293-298.
33. Okabe M, Fukuda K, Arakawa K, et al.: Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation 1997;96:22-24.
34. Matsumori A, Matoba Y, Nishio R, Shioi T, Ono K, and Sasayama S: Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 1996;222:678-682. (Pubitemid 26194811)
35. Buckley MG, Sethi D, Markandu ND, Sagnella GA, Singer DRJ, and MacGregor GA: Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci 1992;83:437-444.
36. Khan IA, Fink J, Nass C, Chen H, Christenson R, and De-Filippi CR: N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients, Am J Cardiol 2006;97:1530-1534.
37. Vickery S, Price CP, John RI, Abbas NA, Webb MC, Kempson ME, et al.: B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: Relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis 2005;46:610-620.
38. De Castro S, Migliau G, Silvestri A, D'Amati G, Giannantoni P, Cartoni D, et al.: Heart involvement in AIDS: A prospective study during various stages of the disease. Eur Heart J 1992;13:1452-1459.
39. Kaplan RC, Kingsley LA, Gange SJ, Benning L, Jacobson LP, Lazar J, et al.: Low CD4+T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 2008;22:1615-1624.
40. Chang AY, Abdullah SM, Jain T, Stanek HG, Das SR, McGuire DK, Auchus RJ, and Lemos JA: Associations among androgens, estrogens, and natriuretic peptides in young women: Observations from the Dallas Heart Study. J Am Coll Cardiol 2007;49:109-116.
41. Dieplinger B, Poelz W, Haltmayer M, and Mueller T: Association of adiponectin and amino terminal proBNP in peripheral arterial disease. Clin Chim Acta 2007;377:192-197.
42. Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP: INDANA Project Steering Committee: Individual data analysis of antihypertensive intervention. J-shaped relationship between blood pressure and mortality in hypertensive patients: New insights from a meta-analysis of individualpatient data. Ann Intern Med 2002;136:438-448.
43. Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, et al.: Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Am J Cardiol 2008;102:733-737.
44. Sugrue DD, Rodeheffer RJ, Codd MB, Ballard DJ, Fuster V, and Gersh BJ: The clinical course of idiopathic dilated cardiomyopathy: A population-based study. Ann Intern Med 1992;117:117-123